Prime Medicine, Inc. (PRME) Earning

$3.11

$0.04 (1.3%)
Last update: 01:00 PM EST
Day's range
$3.02
Day's range
$3.5
PRME Earnings Estimates and Actuals by Quarter$0$0-$5-$5-$10-$10-$15-$15-$20-$20Q3 2023Q3 2023Q1 2024Q1 2024Q3 2024Q3 2024Q1 2025Q1 2025Q3 2025Q3 2025Q1 2026Q1 2026Q3 2026Q3 2026Q1 2021Q1 2021Q3 2021Q3 2021
Actual EPS
Download SVG
Download PNG
Download CSV

Prime Medicine, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2025 3 -$0.35 -$0.25 -$0.31
Q2 2025 9 -$0.43 -$0.27 -$0.36
Q3 2025 4 -$0.29 -$0.29 -$0.29
Q4 2025 7 -$0.24 -$0.24 -$0.24
Q1 2026 7 -$0.31 -$0.31 -$0.31
Q2 2026 3 -$0.30 -$0.30 -$0.30
Q3 2026 3 -$0.28 -$0.28 -$0.28
Q4 2026 7 -$0.28 -$0.28 -$0.28

Prime Medicine, Inc. Earnings Date And Information

Prime Medicine, Inc. last posted its earnings results on Thursday, May 8th, 2025. The company reported $-0.4 earnings per share for the quarter, missing analysts' consensus estimates of $-0.32 by $0.08. The company had revenue of 1.45 M for the quarter and had revenue of 2.98 M for the year. Prime Medicine, Inc. has generated $-2 earnings per share over the last year ($-1.65 diluted earnings per share) and currently has a price-to-earnings ratio of -2.01. Prime Medicine, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 7th, 2025 based on prior year's report dates.

Prime Medicine, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
05/08/2025 Q1 2025 -$0.32 -$0.40 -0.08 $4.49 M $1.45 M
02/28/2025 Q4 2024 -$0.37 -$0.35 0.02 $6.78 M $2.18 M
11/12/2024 Q3 2024 -$0.43 -$0.44 -0.01 $7.09 M $209.00 K
08/08/2024 Q2 2024 -$0.40 -$0.46 -0.06 $1.63 M $37.77 M
05/10/2024 Q1 2024 -$0.45 -$0.44 0.01 $1.92 M $591.00 K
03/01/2024 Q4 2023 -$0.48 -$0.67 -0.19 $5.71 M $0
11/03/2023 Q3 2023 -$0.45 -$0.55 -0.1 $1.67 M $0
08/07/2023 Q2 2023 -$0.42 -$0.47 -0.05 N/A $0
05/11/2023 Q1 2023 -$0.42 -$0.44 -0.02 N/A $0
03/09/2023 Q4 2022 -$0.65 -$0.57 0.08 N/A $0
11/14/2022 Q3 2022 N/A -$0.38 N/A N/A $0
06/30/2022 Q2 2022 N/A -$0.50 N/A N/A $0
03/31/2022 Q1 2022 N/A -$0.42 N/A N/A $0
12/31/2021 Q4 2021 N/A -$0.96 N/A N/A $0
09/30/2021 Q3 2021 N/A -$0.32 N/A N/A $0
06/30/2021 Q2 2021 N/A -$0.04 N/A N/A $9.13 M
03/31/2021 Q1 2021 N/A -$12.15 N/A N/A $0
12/31/2020 Q4 2020 N/A -$0.04 N/A N/A $0
12/30/2019 Q4 2019 N/A -$0.04 N/A N/A $0

Prime Medicine, Inc. Earnings: FAQ's

Prime Medicine, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 7th, 2025 based offlast year's report dates.

The conference call for Prime Medicine, Inc.'s latest earnings report can be listened to online.

The conference call transcript for Prime Medicine, Inc.'s latest earnings report can be read online.

Prime Medicine, Inc. (:PRME) has a recorded annual revenue of $2.98 M.

Prime Medicine, Inc. (:PRME) has a recorded net income of $-195,882,000.Prime Medicine, Inc. has generated $-1.65 earnings per share over the last four quarters.

Prime Medicine, Inc. (:PRME) has a price-to-earnings ratio of -2.01 and price/earnings-to-growth ratio is -0.85.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED